The right ventricle in pulmonary arterial hypertension

Robert Naeije, Alessandra Manes, Robert Naeije, Alessandra Manes

Abstract

Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. In early-stage PAH, the right ventricle tends to remain adapted to afterload with increased contractility and little or no increase in right heart chamber dimensions. However, less than optimal right ventricular (RV)-arterial coupling may already cause a decreased aerobic exercise capacity by limiting maximum cardiac output. In more advanced stages, RV systolic function cannot remain matched to afterload and dilatation of the right heart chamber progressively develops. In addition, diastolic dysfunction occurs due to myocardial fibrosis and sarcomeric stiffening. All these changes lead to limitation of RV flow output, increased right-sided filling pressures and under-filling of the left ventricle, with eventual decrease in systemic blood pressure and altered systolic ventricular interaction. These pathophysiological changes account for exertional dyspnoea and systemic venous congestion typical of PAH. Complete evaluation of RV failure requires echocardiographic or magnetic resonance imaging, and right heart catheterisation measurements. Treatment of RV failure in PAH relies on: decreasing afterload with drugs targeting pulmonary circulation; fluid management to optimise ventricular diastolic interactions; and inotropic interventions to reverse cardiogenic shock. To date, there has been no report of the efficacy of drug treatments that specifically target the right ventricle.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

©ERS 2014.

Figures

Figure 1.
Figure 1.
Right ventricular (RV) pressure–volume loops at decreasing venous return in a patient with a) systemic sclerosis-associated pulmonary arterial hypertension (PAH) and b) idiopathic PAH. The mean pulmonary artery pressure of both patients was similar. The slope of linearised maximum elastance pressure–volume relationship was higher in the patient with IPAH, indicating higher contractility. Note the maximum RV pressure close to the pressure at maximum elastance in both patients. Reproduced from [14] with permission from the publisher.
Figure 2.
Figure 2.
The a) volume, b) pressure, c) single-beat and d) diastolic stiffness methods used to estimate right ventricular (RV)–arterial coupling and diastolic stiffness. a, b), Arterial elastance (Ea) is calculated from the ratio of end-systolic pressure (ESP) to stroke volume (SV). a) End-systolic elastance (Ees) as an approximation of maximum elastance is estimated by the ratio of ESP to end systolic volume (ESV), which results in a simplified Ees/Ea of SV/ESV. b) Maximum pressure (Pmax) is estimated from the non-linear extrapolation of the early systolic and diastolic portions of the RV pressure curve. Ees is then the ratio of Pmax−mPAP/SV, where mPAP is mean pulmonary artery pressure. This results in a simplified Ees/Ea of Pmax/ESP−1. c) Ees is calculated as a straight line drawn from the Pmax tangent to sRVP–relative change in volume relationship. d) Diastolic stiffness (β) is calculated by fitting the non-linear exponential, P = α(eVβ−1), to the pressure and volume measured at the beginning of diastole. Where P is pressure, α is curve fit constant and V is volume. EDV: end diastolic volume; Evol: Ees by the volume method; sRVP: systolic RV pressure; PA: pulmonary artery; BDP: beginning diastolic pressure; EDP: end-diastolic pressure. Reproduced from [17] with permission from the publisher.
Figure 3.
Figure 3.
The right ventricle between “a rock and a hard place”, challenged by the pressure overload and the sick lung circulation. The grey circles symbolise cellular and molecular mechanisms. RVF: right ventricular failure. Reproduced from [25] with permission from the publisher.
Figure 4.
Figure 4.
A pump function graph demonstrating mean right ventricular pressure as a function of stroke volume (SV). Maximum mean right ventricular pressure is calculated from nonlinear extrapolations of early and late systolic portions of the right ventricular pressure curve. SV is calculated by dividing cardiac output by heart rate. The curve is a parabolic fit of two data points: maximum mean right ventricular pressure and measured mean right ventricular pressure/SV. At high right ventricular pressure, a small decrease in pressure results in a large increase in SV. PVR: pulmonary vascular resistance. Reproduced from [2] with permission from the publisher.
Figure 5.
Figure 5.
Pathophysiology of right ventricular (RV) failure. Pulmonary hypertension increases RV afterload requiring a homeometric adaptation, i.e. an increased RV contractility. When this adaptation fails, the RV enlarges with increased end-diastolic volume (EDV), decreasing left ventricle preloading because of competition for space within the pericardium. This decreases stroke volume (SV) and blood pressure, with negative systolic interaction as a cause of further RV–arterial uncoupling, which may be aggravated by RV ischaemia from decreased coronary perfusion pressure (gradient between diastolic blood pressure and right atrial pressure). Obvious targets for interventions are indicated as 1 to 4. See the A global view on RV failure section for further details. iNO: inhaled nitric oxide; iILO: inhaled iloprost; PDE5i: phosphodiesterase type-5 inhibitor; ERA: endothelin receptor antagonist; PGI2: prostaglandin I2; FRC: functional residual capacity.

References

    1. Hoeper MM, Bogaard HJ, Condliffe R, et al. . Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D45 D50 .
    1. Vonk-Noordegraaf A, Haddad F, Chin KM, et al. . Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 2013; 62: Suppl. 25, D22 D33 .
    1. Haddad F, Hunt SA, Rosenthal DN, et al. . Right ventricular function in cardiovascular disease, part I. Anatomy, physiology, aging and functional assessment of the right ventricle. Circulation 2008; 117: 1436–1448.
    1. Guyton AC, Lindsey AW, Gilluly JJ. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ Res 1954; 2: 326–332.
    1. Sagawa K, Maughan L, Suga H, eds, et al.. Cardiac Contraction and the Pressure-Volume Relationship. Oxford, Oxford University Press, 1988.
    1. Sarnoff SJ, Mitchell JH, Gilmore JP, et al. . Homeometric autoregulation of the heart. Circ Res 1960; 8: 1077–1091.
    1. von Anrep G. On the part played by the suprarenals in the normal vascular reactions of the body. J Physiol 1912; 45: 307–317.
    1. Taquini AC, Fermoso JD, Aramendia P. Behaviour of the right ventricle following acute constriction of the pulmonary artery. Circ Res;1960: 315–318.
    1. Vonk-Noordegraaf A, Westerhof N. Describing right ventricular function. Eur Respir J 2013; 41: 1419–1423.
    1. Naeije R, Brimioulle S, Dewachter C. Biomechanics of the right ventricle. Pulm Circ 2014; 4: 395–406.
    1. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 1973; 32: 314–322.
    1. Maughan WL, Shoukas AA, Sagawa K, et al. . Instantaneous pressure-volume relationship of the canine right ventricle. Circ Res 1979; 44: 309–315.
    1. Redington AN, Rigby RL, Shinebourne EA, et al. . Changes in pressure-volume relation of the right ventricle when its loading conditions are modified. Br Heart J 1990; 63: 45–49.
    1. Tedford RJ, Mudd JO, Girgis RE, et al. . Right ventricular dysfunction in systemic sclerosis associated pulmonary arterial hypertension. Circulation Heart Fail 2013; 6: 953–963.
    1. Sunagawa K, Yamada A, Senda Y, et al. . Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 1980; 57: 299–305.
    1. Brimioulle S, Wauthy P, Ewalenko P, et al. . Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284: H1625–H1630.
    1. Vanderpool RR, Pinsky MR, Naeije R, et al. . RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 2014. [In press DOI: 10.1136/heartjnl-2014-306142].
    1. Dell’Italia LJ, Walsh RA. Application of a time-varying elastance model to right ventricular performance in man. Cardiovasc Res 1988; 22: 864–874.
    1. Kuehne T, Yilmaz S, Steendijk P, et al. . Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004; 110: 2010–2016.
    1. Wauthy P, Naeije R, Brimioulle S. Left and right ventriculo-arterial coupling in a patient with congenitally corrected transposition. Cardiol Young 2005; 15: 647–649.
    1. McCabe C, White PA, Hoole SP, et al. . Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery. J Appl Physiol 2013; 116: 355–363.
    1. Rosenblueth A, Alanis J, Lopez E, et al. . The adaptation of ventricular muscle to different circulatory conditions. Arch Int Physiol Biochim 1959; 67: 358–373.
    1. Bogaard HJ, Abe K, Vonk Noordegraaf A, et al. . The right ventricle under pressure. Cellular and molecular mechanisms of right heart failure in pulmonary hypertension. Chest 2009; 135: 794–780.
    1. Voelkel NF, Gomez-Arroyo J, Abbate A, et al. . Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J 2012; 40: 1555–1565.
    1. Voelkel NF, Gomez-Arroyo J, Abbate A, et al. . Mechanisms of right heart failure – a work in progress and plea for further prevention. Pulm Circ 2013; 3: 137–143.
    1. Gómez A, Bialostozky D, Zajarias A, et al. . Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001; 38: 1137–1141.
    1. Dewachter C, Dewachter L, Rondelet B, et al. . Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med 2010; 38: 1405–1413.
    1. Belhaj A, Dewachter L, Kerbaul F, et al. . Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension. PLoS One 2013; 8: e69470.
    1. Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011; 184: 1114–1124.
    1. Sztrymf B, Günther S, Artaud-Macari E, et al. . Left ventricular ejection time in acute heart failure complicating pre-capillary pulmonary hypertension. Chest 2013; 144: 1512–1520.
    1. Kerbaul F, Rondelet B, Motte S, et al. . Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004; 32: 1035–1040.
    1. de Man FS, Handoko ML, van Ballegoij JJ, et al. . Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail 2012; 5: 97–105.
    1. Bogaard HJ, Natarajan R, Mizuno S, et al. . Adrenergic blockade reverses right heart remodeling and dysfunction in pulmonary hypertensivre rats. Am J Respir Crit Care Med 2010; 182: 652–656.
    1. Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 1999; 34: 1184–1187.
    1. Nagendran J, Archer SL, Soliman D, et al. . Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007; 116: 238–248.
    1. Wauthy P, Kafi AS, Mooi W, et al. . Effects of nitric oxide and prostacyclin in an over-circulation model of pulmonary hypertension. J Thorac Cardiovasc Surg 2003; 125: 1430–1437.
    1. Kerbaul F, Brimioulle S, Rondelet B, et al. . How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 2007; 175: 846–850.
    1. Rex S, Missant C, Segers P, et al. . Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Intens Care Med 2008; 34: 179–189.
    1. Fesler P, Pagnamenta A, Rondelet B, et al. . Effects of sildenafil on hypoxic pulmonary vascular function in dogs. J Appl Physiol 2006; 101: 1085–1090.
    1. Borgdorff MA, Bartelds B, Dickinson MG, et al. . Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle. Eur J Heart Fail 2012; 14: 1067–1074.
    1. Rondelet B, Kerbaul F, Motte S, et al. . Bosentan for the prevention of overcirculation-induced pulmonary hypertension. Circulation 2003; 107: 1329–1335.
    1. Sanz J, García-Alvarez A, Fernández-Friera L, et al. . Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 2012; 98: 238–243.
    1. Trip P, Kind T, van de Veerdonk MC, et al. . Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. J Heart Lung Transplant 2013; 32: 50–55.
    1. van de Veerdonk MC, Kind T, Marcus JT, et al. . Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58: 2511–2519.
    1. Sniderman AD, Fitchett DH. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. Int J Cardiol 1988; 20: 173–181.
    1. Zhang QB, Sun JP, Gao RF, et al. . Feasibility of single-beat full volume capture real-time three-dimensional echocardiography for quantification of right ventricular volume: validation by cardiac magnetic resonance imaging. Int J Cardiol 2013; 168: 3991–3995.
    1. Elzinga G, Westerhof N. The effect of an increase in inotropic state and end-diastolic volume on the pumping ability of the feline left heart. Circ Res 1978; 42: 620–628.
    1. Overbeek MJ, Lankhaar JW, Westerhof N, et al. . Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Eur Respir J 2008; 31: 1160–1166.
    1. Haddad F, Vrtovec B, Ashley EA, et al. . The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction. Curr Opin Cardiol 2011; 26: 123–131.
    1. Faber MJ, Dalinghaus M, Lankhuizen IM, et al. . Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Heart Circ Physiol 2006; 291: H1580–H1586.
    1. Grünig E, Tiede H, Enyimayew EO, et al. . Assessment and prognostic relevance of right ventricular contractile reserve in patients with pulmonary arterial hypertension. Circulation 2013; 128: 2005–2015.
    1. Saouti N, Westerhof N, Helderman F, et al. . Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med 2010; 182: 1315–1320.
    1. Bossone E, D’Andrea A, D’Alto M, et al. . Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 2013; 26: 1–14.
    1. Roberts JD, Forfia PR. Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography. Pulm Circ 2011; 1: 160–181.
    1. Ernande L, Cottin V, Leroux PY, et al. . Right isovolumic contraction velocity predicts survival in pulmonary hypertension. J Am Soc Echocardiogr 2013; 26: 297–306.
    1. Vogel M, Schmidt MR, Christiansen SB, et al. . Validation of myocardial acceleration during isovolumic contraction as a novel non-invasive index of right ventricular contractility. Circulation 2002; 105: 1693–1699.
    1. Rain S, Handoko ML, Trip P, et al. . Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 2013; 128: 2016–2025.
    1. Santamore WP, Dell’Italia LJ. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Progr Cardiovasc Dis 1998; 40: 289–308.
    1. Lazar JM, Flores AR, Grandis DJ, et al. . Effects of chronic right ventricular pressure overload on left ventricular diastolic function. Am J Cardiol 1993; 72: 1179–1182.
    1. Belenkie I, Horne SG, Dani R, et al. . Effects of aortic constriction during experimental acute right ventricular pressure loading. Further insights into diastolic and systolic ventricular interaction. Circulation 1995; 92: 546–554.
    1. Damiano RJ, Jr, La Follette P, Jr, Cox JL, et al. . Significant left ventricular contribution to right ventricular systolic function. Am J Physiol 1991; 261: H1514–H1524.
    1. Marcus JT, Gan CT, Zwanenburg JJ, et al. . Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008; 51: 750–757.
    1. Huez S, Faoro V, Vachiery JL, et al. . Images in cardiovascular medicine. High-altitude-induced right-heart failure. Circulation 2007; 115: e308–e309.
    1. Smith BC, Dobson G, Dawson D, et al. . Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 2014; 64: 41–51.

Source: PubMed

3
Iratkozz fel